About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Illinois | 545 Studies

Clinical Trials Prostate CancerIllinois

Prostate Cancer Clinical Trials in Illinois

Find 545 clinical trials for prostate cancer near Illinois. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 545 trials

Active not recruitingA Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsThis is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy of ST101 administered IV in…NCT04478279·San Francisco, California and 10 others Active not recruitingA Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate CancerProstate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men worldwide.NCT06318273·Duarte, California and 25 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and…NCT07611110·Dothan, Alabama and 150 others

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 581 others

CompletedAn Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair AnomaliesThe purpose of this study is to assess the efficacy, safety, and pharmacokinetics of niraparib in men with metastatic castration-resistant prostate cancer (mCRPC) and…NCT02854436·Tucson, Arizona and 109 others

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

CompletedBicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerThis randomized phase II trial is studying bicalutamide, goserelin, or leuprolide acetate to see how well they work when given with or without cixutumumab in treating patients…NCT01120236·Fairbanks, Alaska and 169 others

TerminatedStudy of HPN424 in Patients With Advanced Prostate CancerAn open-label, Phase 1/2a, study of HPN424 as monotherapy to assess the safety, tolerability and PK in patients with advanced prostate cancer refractory to androgen therapyNCT03577028·Los Angeles, California and 14 others

CompletedRadiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002874·Birmingham, Alabama and 239 others

CompletedS1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerThe purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700…NCT01809691·Birmingham, Alabama and 559 others

CompletedChemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00005847·Denver, Colorado and 18 others

RecruitingStudy of ORIC-944 in Patients With Metastatic Prostate CancerThe purpose of this study is to establish the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic…NCT05413421·Colorado Springs, Colorado and 26 others

Active not recruitingA Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryPatients with post-prostatectomy PSA (Prostate Specific Antigen) recurrences with aggressive disease features will receive salvage radiation therapy and standard androgen…NCT03809000·Gilbert, Arizona and 107 others

WithdrawnDocetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate CancerThe main purpose of this study is to find out whether adding radiation therapy to the standard treatment of chemotherapy for prostate cancer is tolerated well and is more…NCT01087580·Chicago, Illinois and 1 other

CompletedPhase II Sunitinib Prog Met AIPCThe purpose of this research study is to find out what effects (good and bad) Sutent has on you and your prostate cancer.NCT00599313·Phoenix, Arizona and 44 others

RecruitingOpen-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyThis is a Phase II/III study.NCT06780670·Scottsdale, Arizona and 92 others

CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005810·San Francisco, California and 6 others

RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including…NCT06465069·Duarte, California and 39 others

RecruitingREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaThis study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combination with REGN4336 in adult patients with mCRPC and ccRCC.NCT07594106·Goodyear, Arizona and 5 others

CompletedCopper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate CancerThis is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate cancer after radical…NCT06235099·Fullerton, California and 30 others

PreviousPage 3 of 28Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma